Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Thomas

Showing results (141-150 of 262) with videos related to

Pageof 27
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases|May 13, 2020
Lyon-University Hospital Experience with Gemtuzumab Ozogamicin Therapy in Acute Myeloid Leukemia: a 'Real-Life' StudyMarica Laurino, Sandrine Loron, Marie-Virginie Larcher, et al.
Blood|March 18, 2009
The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplicationAline Renneville, Nicolas Boissel, Nathalie Gachard, et al.
Blood Advances|August 15, 2023
Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trialJorge Sierra, Pau Montesinos, Xavier Thomas, et al.
Cancer Medicine|February 2, 2022
Isatuximab monotherapy in patients with refractory T-acute lymphoblastic leukemia or T-lymphoblastic lymphoma: Phase 2 studyNicolas Boissel, Patrice Chevallier, Vadim Doronin, et al.
Genetica|October 23, 2009
The mariner Mos1 transposase produced in tobacco is active in vitroXavier Thomas, Sabah Hedhili, Laurent Beuf, et al.
Experimental Hematology|June 19, 2012
Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimensMarie Detrait, Valérie Dubois, Mohamad Sobh, et al.
Cancer|August 22, 2019
Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 studyElias J Jabbour, Nicola Gökbuget, Hagop M Kantarjian, et al.
Haematologica|March 15, 2006
Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemiaSophie Ducastelle, Lionel Adès, Claude Gardin, et al.
Leukemia & Lymphoma|December 8, 2011
Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trialGiovanna Cannas, Cécile Pautas, Emmanuel Raffoux, et al.
Experimental Hematology|November 9, 2010
Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemiasValérie Capraro, Linda Zane, Delphine Poncet, et al.
Pageof 27

Showing results (141-150 of 262) with videos related to

Sort By:
Pageof 27
Mediterranean Journal of Hematology and Infectious Diseases|May 13, 2020
Lyon-University Hospital Experience with Gemtuzumab Ozogamicin Therapy in Acute Myeloid Leukemia: a 'Real-Life' StudyMarica Laurino, Sandrine Loron, Marie-Virginie Larcher, et al.
Blood|March 18, 2009
The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplicationAline Renneville, Nicolas Boissel, Nathalie Gachard, et al.
Blood Advances|August 15, 2023
Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trialJorge Sierra, Pau Montesinos, Xavier Thomas, et al.
Cancer Medicine|February 2, 2022
Isatuximab monotherapy in patients with refractory T-acute lymphoblastic leukemia or T-lymphoblastic lymphoma: Phase 2 studyNicolas Boissel, Patrice Chevallier, Vadim Doronin, et al.
Genetica|October 23, 2009
The mariner Mos1 transposase produced in tobacco is active in vitroXavier Thomas, Sabah Hedhili, Laurent Beuf, et al.
Experimental Hematology|June 19, 2012
Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimensMarie Detrait, Valérie Dubois, Mohamad Sobh, et al.
Cancer|August 22, 2019
Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 studyElias J Jabbour, Nicola Gökbuget, Hagop M Kantarjian, et al.
Haematologica|March 15, 2006
Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemiaSophie Ducastelle, Lionel Adès, Claude Gardin, et al.
Leukemia & Lymphoma|December 8, 2011
Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trialGiovanna Cannas, Cécile Pautas, Emmanuel Raffoux, et al.
Experimental Hematology|November 9, 2010
Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemiasValérie Capraro, Linda Zane, Delphine Poncet, et al.
Pageof 27